Michael Sweeting
@michaelsweeting
Followers
453
Following
299
Media
0
Statuses
105
Biostatistician. @AstraZeneca. Honorary Fellow @uniofleicester. Enjoy walking in hills and following English cricket. All views, political & otherwise, my own.
Leicester, England
Joined October 2009
Check out our new preprint on an efficient simulation method for comparing dose-finding designs Thanks to #AstraZeneca co-authors and especially @CatchTwentyToo for implementing in the escalation package with accompanying blog
kristianbrock.com
A simple, efficient method for comparing dose-finding designs described in preprint and implemented in escalation v0.1.8
2
2
6
Hi @CambsCC . With the traffic into Cambridge at a standstill most days why do you still insist on charging people over £20 if they park at one of your park and ride sites for more than a day? We don't all come in and out of the city in a day.
2
0
2
I'm delighted to announce publication of a new tutorial article on use of excess hazard models for HTA survival extrapolation with accompanying R and Stata code. Huge thanks to .@MJRutherford9 @danj_statsguru @NRLatimer @pclambert123 and all co-authors.
journals.sagepub.com
Background Different parametric survival models can lead to widely discordant extrapolations and decision uncertainty in cost-effectiveness analyses. The use of...
0
8
23
RT @pounce321: Proud to present this work in the @BJSurgery thanks to Janet Powell @ImperialVasc @BicknellColin @mi….
academic.oup.com
This study used data from the National Vascular Registry (21 810 patients; 2380 women and 19 430 men) to investigate whether sex-specific differences in pr
0
2
0
RT @beyondcancer0: New @BJGPjournal paper out from our team! We found that cancer history should be considered as .a predictor in future ca….
0
7
0
RT @HeatherPoad: Presenting my poster: Exploration of the impact of the treatment mechanism of action on the surrogate relationship between….
0
2
0
We have an exciting opportunity for a #postdoc to join the Oncology Biometrics team at #AstraZeneca in Cambridge, UK. Working with myself at #AstraZeneca and @pclambert123 at #UniversityOfLeicester. Please feel free to DM if you have any questions!.
0
3
6
RT @betty_syriop: 📢Our paper on estimating causal effects in the presence of competing events is now available open access at https://t.co/….
0
43
0
RT @cjackstats: flexsurv is also now included in the #tidymodels ecosystem through .that is newly on CRAN. Thanks @….
0
4
0
Huge thanks to @cjackstats for allowing the add-on to flexsurv and @pclambert123 for the incredible Stata version, which I’ve shamelessly copied!. 🧵3/3.
0
0
6
Features:.-Standardized survival, hazard and RMST.-Expected and all-cause survival and hazard from relative survival models.-Marginal contrasts.-Confidence intervals + SEs .-Beautiful customisable ggplots . 🧵 2/3.
1
1
3
Very excited to announce a new post-estimation command -standsurv- in R for calculating marginal estimates after fitting a flexsurv parametric survival model.Check out the vignette . #rstats. 🧵 1/3.
1
13
51
RT @96HayleySmith: My first paper has been published in BMC Diagnostic and Prognostic Research!🥳 Big thanks to co-authors @Crowther_MJ @mic….
diagnprognres.biomedcentral.com
Background There is substantial interest in the adaptation and application of so-called machine learning approaches to prognostic modelling of censored time-to-event data. These methods must be...
0
13
0
RT @MJRutherford9: NEW PAPER: Want to fairly compare cancer survival outcomes across groups with different other-cause mortality risks? Tir….
0
15
0
RT @UoL_Health_Sci: JOBS | Res Associate (Biostatistician) to work on methodological and computational development for statistical analysis….
0
13
0
RT @jack_bowdenjack: Exciting opportunity for a statistician or data scientist to work with me, Frank Dudbridge, @lcpilling @timfrayling….
0
11
0
RT @stats_ci: The beauty of living reference work and Bayesian Adaptive Designs for Phase I trials. Some good news from @DrGWheeler . https….
statsci.co.uk
Over the years, I’ve amassed a collection of textbooks that have proven useful at one stage or another. However, as time goes by, the only things they gain are a thin layer of dust and minor wear and...
0
7
0